Capital International Investors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,864
| Closed | -$344K | – | 456 |
|
|
2021
Q4 | $344K | Sell |
3,864
-543,937
| -99% | -$48.4M | ﹤0.01% | 457 |
|
|
2021
Q3 | $42.3M | Sell |
547,801
-242
| -0% | -$18.7K | 0.01% | 362 |
|
|
2021
Q2 | $45.7M | Buy |
548,043
+1,102
| +0.2% | +$92K | 0.01% | 366 |
|
|
2021
Q1 | $41.3M | Buy |
546,941
+280
| +0.1% | +$21.1K | 0.01% | 353 |
|
|
2020
Q4 | $47.9M | Buy |
546,661
+936
| +0.2% | +$82.1K | 0.01% | 335 |
|
|
2020
Q3 | $41.5M | Sell |
545,725
-429,601
| -44% | -$32.7M | 0.01% | 327 |
|
|
2020
Q2 | $120M | Buy |
975,326
+1,797
| +0.2% | +$222K | 0.04% | 242 |
|
|
2020
Q1 | $82.3M | Sell |
973,529
-1,593,708
| -62% | -$135M | 0.03% | 228 |
|
|
2019
Q4 | $217M | Buy |
2,567,237
+1,454
| +0.1% | +$123K | 0.07% | 185 |
|
|
2019
Q3 | $173M | Buy |
2,565,783
+764,300
| +42% | +$51.5M | 0.07% | 194 |
|
|
2019
Q2 | $154M | Buy |
1,801,483
+24,664
| +1% | +$2.11M | 0.06% | 208 |
|
|
2019
Q1 | $158M | Sell |
1,776,819
-1,635,825
| -48% | -$145M | 0.07% | 196 |
|
|
2018
Q4 | $291M | Buy |
3,412,644
+1,308,641
| +62% | +$111M | 0.14% | 150 |
|
|
2018
Q3 | $204M | Buy |
+2,104,003
| New | +$204M | 0.09% | 179 |
|